Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Delayed Quote. Delayed  - 07/27 05:35:01 pm
94.62 EUR   +1.12%
07/27 Using innovation to make chemical transport safe
07/27DJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- 3rd..
07/27DJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- 2nd..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer AG : EARNINGS FORECAST TABLE : Bayer 4Q 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/22/2013 | 02:32pm CEST

FRANKFURT--The following is a summary of analysts' forecasts for Bayer AG (BAYN.XE) fourth-quarter results, based on a poll of 10 analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released February 28.

=== 
 
                          EBITDA   EBITDA   EBIT    EBIT 
4th Quarter        Sales    adj.    rep.    adj.  reported 
 
AVERAGE            9,726   1,811   1,585   1,092     901 
Prev. Year         9,191   1,541   1,415     844     629 
+/- in %            +5.8     +18     +12     +29     +43 
 
MEDIAN             9,743   1,821   1,585   1,102     841 
Maximum            9,905   1,893   1,633   1,191   1,053 
Minimum            9,536   1,707   1,536     970     808 
Amount (a)            10      10       2       6       5 
 
Baader Bank        9,725   1,839      --      --      -- 
Credit Suisse      9,793   1,831      --   1,191     966 
Deutsche Bank      9,559   1,869      --   1,135   1,053 
Equinet            9,760   1,820      --      --     838 
Exane BNP Paribas  9,611   1,817      --     970      -- 
J.P. Morgan        9,883   1,821   1,633   1,125      -- 
Nomura             9,536   1,707      --   1,078     808 
UBS                9,840   1,760      --      --      -- 
 
 
 
                  Net attrib.             EPS 
4th Quarter         income      EPS      core 
 
AVERAGE              468       0.55      1.06 
Prev. Year           397       0.48      0.97 
+/- in %             +18        +15      +9.3 
 
MEDIAN               494       0.53      1.06 
Maximum              549       0.66      1.12 
Minimum              332       0.46      1.00 
Amount (a)             8          6        10 
 
Baader Bank          542         --      1.02 
Credit Suisse        466       0.56      1.05 
Deutsche Bank        538         --      1.05 
Equinet               --       0.50      1.08 
Exane BNP Paribas    332         --      1.09 
J.P. Morgan          521       0.63      1.06 
Nomura               413       0.50      1.00 
UBS                   --         --      1.03 
 
 
 
               Target price  Rating                 DPS 2012 
 
AVERAGE               77.27  positive 6     AVERAGE     1.84 
Prev. Quarter         67.20  neutral  3     Prev. Year  1.65 
+/- in %                +15  negative 1     +/- in %     +11 
 
MEDIAN                75.00                 MEDIAN      1.83 
Maximum               90.00                 Maximum     1.94 
Minimum               65.60                 Minimum     1.77 
Amount                    9                 Amount         6 
 
Baader Bank           65.60  Hold                         -- 
Barclays              66.00  Underweight                1.81 
Citigroup             90.00  Buy                        1.85 
Commerzbank           90.00  Buy                          -- 
Credit Suisse         82.80  Outperform                 1.94 
Deutsche Bank         86.00  Buy                        1.77 
Equinet               75.00  Accumulate                 1.85 
Exane BNP Paribas     73.00  Neutral                    1.80 
J.P. Morgan              --  Overweight                   -- 
UBS                   67.00  Neutral                      -- 
=== 

Year-earlier figures are as reported by the company.

(a) Including anonymous estimates from two more institutes.

DJG/voi 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
07/27 Using innovation to make chemical transport safe
07/27DJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- 3rd Update
07/27DJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- 2nd Update
07/27DJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- Update
07/27 BAYER : raises sales and earnings
07/27DJBayer Reports Higher Second-Quarter Profit, Raises Guidance
07/27DJBAYER : Second-Quarter Profit Rises 18.6%
07/27DJBAYER : Second-Quarter Profit Rises 18.6%
07/26 COVESTRO : reports profits jumped by 51 percent
07/22DJBAYER : 2Q 2016 -- Forecast
More news
Sector news : Pharmaceuticals - NEC
05:38a Fosun agrees to buy KKR-backed Indian drugmaker for $1.4 billion - source
07/27 Teva, Allergan win U.S. antitrust approval for generics deal
07/27DJTEVA PHARMACEUTICAL : Correction to Teva, Allergan Article
07/27DJRenault Board Cuts CEO's 2016 Pay After Spat With Shareholders
07/27DJALERE : Faces Criminal Probe Over Medicare, Medicaid Billing -- Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/27 BASF, Bayer agrochemicals outlook adds impetus for dealmaking
07/27 Bayer's (BAYZF) CEO Werner Baumann on Q2 2016 Results - Earnings Call Transcr..
07/27 Bayer A.G. reports Q2 results
07/27 Bayer Q2 top line off 1%; EPS up 19%; cash flow ops up 1%
07/25 RETIREMENT STRATEGY : 5 Pharmaceutical Dividends To Buy Here